Yeh, Yen-Hsiu <br/><br/>
Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.  [electronic resource] 

 -  Oncology reports  May 2016 
 - 2887-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2016.4664  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Drug Screening Assays, Antitumor<br/>Epithelial-Mesenchymal Transition<br/>HeLa Cells<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteolysis<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction<br/>Snail Family Transcription Factors--metabolism<br/>Stilbenes--pharmacology<br/>TOR Serine-Threonine Kinases--metabolism<br/>Transforming Growth Factor beta1--physiology<br/>Ubiquitination